中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
海洋研究所 [134]
上海药物研究所 [31]
武汉物理与数学研究... [30]
近代物理研究所 [22]
武汉岩土力学研究所 [20]
中国科学院大学 [17]
更多
采集方式
OAI收割 [384]
iSwitch采集 [22]
内容类型
期刊论文 [402]
会议论文 [3]
专著 [1]
发表日期
2025 [5]
2024 [7]
2023 [9]
2022 [28]
2021 [26]
2020 [15]
更多
学科主题
Immunolog... [56]
Fisheries [38]
Marine & ... [37]
Veterinar... [36]
Zoology [24]
Biochemis... [13]
更多
筛选
浏览/检索结果:
共406条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
作者升序
作者降序
UBE4B modulates BET inhibitor sensitivity via KLHL22-JAK2-PIM1 axis in hepatocellular carcinoma
期刊论文
OAI收割
BIOCHEMICAL PHARMACOLOGY, 2025, 卷号: 237, 页码: 19
作者:
Wang, Li
;
Huan, Xia-Juan
;
Song, Shan-Shan
;
Bao, Xu-Bin
;
Tian, Chang-Qing
  |  
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2025/06/23
UBE4B
BET inhibitors
Resistance
KLHL22
JAK2
Noise Reduction Method for Radio Astronomy Single Station Observation Based on Wavelet Transform and Mathematical Morphology
期刊论文
OAI收割
RESEARCH IN ASTRONOMY AND ASTROPHYSICS, 2025, 卷号: 25, 期号: 7
作者:
Qin, Ming-Wei
;
Tang, Rui
;
Zhou, Ying-Hui
;
Lan, Chang-Jun
;
Fu, Wen-Hao
  |  
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2025/07/03
methods: data analysis
techniques: image processing
techniques: spectroscopic
Sun: radio radiation
methods: numerical
The combination of BET and METTL3 inhibitors elicits synergistic antitumor effects in ovarian cancer cells
via
reducing SP1 and BCL-2 expression
期刊论文
OAI收割
LIFE SCIENCES, 2025, 卷号: 368, 页码: 14
作者:
Ou, Ying-Jie
;
Liu, Ben-Jin
;
Xuan, Yi-Fei
;
Bao, Xu-Bin
;
Huan, Xia-Juan
  |  
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2025/04/24
BET inhibitor
METTL3 inhibitor
Combination therapy
SP1
BCL-2
USP7 V517F mutation as a mechanism of inhibitor resistance
期刊论文
OAI收割
NATURE COMMUNICATIONS, 2025, 卷号: 16, 期号: 1, 页码: 14
作者:
Miao, Yu-Ling
;
Fan, Fengying
;
Cheng, Yong-Jun
;
Jia, Li
;
Song, Shan-Shan
  |  
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2025/05/27
Macrophage SUCLA2 coupled glutaminolysis manipulates obesity through AMPK
期刊论文
OAI收割
NATURE COMMUNICATIONS, 2025, 卷号: 16, 期号: 1, 页码: 20
作者:
Peng, Chang
;
Jiang, Haowen
;
Jing, Liya
;
Yang, Wenhua
;
Guan, Xiaotong
  |  
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2025/04/01
Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidin-7 (8H)-one derivatives as potent USP1 inhibitors
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 275, 页码: 18
作者:
Li, Hongrui
;
Liu, Ben-Jin
;
Xu, Jiahao
;
Song, Shan-Shan
;
Ba, Ruixian
  |  
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2024/08/22
USP1 inhibitor
Structure -activity relationships
Olaparib-resistant cell
Alginate/silk fibroin/Zn 2+composite microspheres for site-specific delivery for enhanced ulcerative colitis therapy
期刊论文
OAI收割
CHEMICAL ENGINEERING JOURNAL, 2024, 卷号: 495, 页码: 13
作者:
Du, Yaoyao
;
Jiang, Yuting
;
Song, Yijie
;
Chen, Jie
;
Wu, Yueqian
  |  
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2024/08/22
Ulcerative colitis
Colon targeting
Oral hydrogel microsphere
Intestinal barrier repair
26.86-tesla direct-current magnetic field generated with an all-REBCO superconducting magnet
期刊论文
OAI收割
SUPERCONDUCTOR SCIENCE & TECHNOLOGY, 2024, 卷号: 37
作者:
Zhang, Xintao
;
Hu, Shuai
;
Guo, Liang
;
Hong, Wenzhe
;
Wang, Zhaoran
  |  
收藏
  |  
浏览/下载:73/0
  |  
提交时间:2024/11/20
superconducting magnet
no-insulation
all-REBCO
high-field
Ligand-Receptor Interaction-Induced Intracellular Phase Separation: A Global Disruption Strategy for Resistance-Free Lethality of Pathogenic Bacteria
期刊论文
OAI收割
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2024, 页码: 17
作者:
Yang, Anming
;
Song, Junfeng
;
Li, Jiaqi
;
Li, Youzhi
;
Bai, Silei
  |  
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2024/09/26
The combination of methionine adenosyltransferase 2A inhibitor and methyltransferase like 3 inhibitor promotes apoptosis of non-small cell lung cancer cells and produces synergistic anti-tumor activity
期刊论文
OAI收割
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 卷号: 716, 页码: 12
作者:
Xuan, Yi-Fei
;
Lu, Shan
;
Ou, Ying-Jie
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2024/07/12
MAT2A inhibitor
METTL3 inhibitor
m6A
Combination therapy
NSCLC